(Q43824936)

27 November 2017

title

In vitro/in vivo scaling of alprazolam metabolism by CYP3A4 and CYP3A5 in humans (English)

1 reference

27 November 2017

1 reference

Hirota N

1

1 reference

27 November 2017

Ito K

2

1 reference

27 November 2017

Iwatsubo T

3

1 reference

27 November 2017

Green CE

4

1 reference

27 November 2017

Tyson CA

5

1 reference

27 November 2017

Shimada N

6

1 reference

27 November 2017

Suzuki H

7

1 reference

27 November 2017

Sugiyama Y

8

1 reference

27 November 2017

publication date

1 March 2001

1 reference

Biopharmaceutics and Drug Disposition

27 November 2017

published in

1 reference

27 November 2017

volume

22

1 reference

27 November 2017

issue

2

1 reference

27 November 2017

page(s)

53-71

1 reference

Prediction of in vivo drug disposition from in vitro data based on physiological pharmacokinetics

27 November 2017

cites work

1 reference

Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data

21 January 2018

1 reference

Quantitative prediction of in vivo drug clearance and drug interactions from in vitro data on metabolism, together with binding and transport

21 January 2018

1 reference

In vitro and in vivo drug interactions involving human CYP3A.

21 January 2018

1 reference

Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily.

21 January 2018

1 reference

Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism.

21 January 2018

1 reference

A pharmacokinetic analysis program (multi) for microcomputer

21 January 2018

1 reference

A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations.

21 January 2018

1 reference

Quantitative prediction of in vivo drug-drug interactions from in vitro data based on physiological pharmacokinetics: use of maximum unbound concentration of inhibitor at the inlet to the liver

21 January 2018

1 reference

Comparative single-dose kinetics and dynamics of lorazepam, alprazolam, prazepam, and placebo

21 January 2018

1 reference

Pharmacokinetics and pharmacodynamics of alprazolam after oral and IV administration

21 January 2018

1 reference

Pharmacokinetics and clinical effects of alprazolam following single and multiple oral doses in patients with panic disorder.

21 January 2018

1 reference

A kinetic and dynamic study of oral alprazolam with and without erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in alprazolam metabolism.

21 January 2018

1 reference

Clinical pharmacokinetics of ketoconazole

21 January 2018

1 reference

Influence of food on the pharmacokinetics of ketoconazole

21 January 2018

1 reference

Pharmacokinetics and bioavailability of cimetidine in gastric and duodenal ulcer patients.

21 January 2018

1 reference

Inhibitors of alprazolam metabolism in vitro: effect of serotonin-reuptake-inhibitor antidepressants, ketoconazole and quinidine

21 January 2018

1 reference

Characterization of midazolam metabolism using human hepatic microsomal fractions and hepatocytes in suspension obtained by perfusing whole human livers.

21 January 2018

1 reference

Inhibition of human CYP3A catalyzed 1'-hydroxy midazolam formation by ketoconazole, nifedipine, erythromycin, cimetidine, and nizatidine.

21 January 2018

1 reference

Urinary screening for alprazolam and its major metabolites by the Abbott ADx and TDx analyzers with confirmation by GC/MS

21 January 2018

1 reference

Ketoconazole inhibition of triazolam and alprazolam clearance: differential kinetic and dynamic consequences

21 January 2018

1 reference

Interaction of cimetidine with the triazolobenzodiazepines alprazolam and triazolam

21 January 2018

1 reference

Methotrexate Pharmacokinetics

21 January 2018

1 reference

Computer simulation of sulfobromophthalein kinetics in the rat using flow-limited models with extrapolation to man

21 January 2018

1 reference

Alprazolam Pharmacokinetics in Alcoholic Liver Disease

21 January 2018

1 reference

Comparison of alprazolam plasma levels in normal Asian and Caucasian male volunteers

21 January 2018

1 reference

Alprazolam pharmacokinetics in women on low-dose oral contraceptives

21 January 2018

1 reference

Alprazolam in end-stage renal disease: I. Pharmacokinetics

21 January 2018

1 reference

Multiple dose pharmacokinetics of ketoconazole and their effects on antipyrine kinetics in man

21 January 2018

1 reference

Pharmacokinetics of cimetidine after single doses and during continuous treatment

21 January 2018

1 reference

The metabolism of [14C]cimetidine in man

21 January 2018

1 reference

Alprazolam metabolism in vitro: studies of human, monkey, mouse, and rat liver microsomes

21 January 2018

1 reference

Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily

21 January 2018

1 reference

Reduction of 3'-azido-3'-deoxythymidine to 3'-amino-3'-deoxythymidine in human liver microsomes and its relationship to cytochrome P450

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/BDD.261

1 reference

27 November 2017

1 reference